Ultrasonically targeted delivery into endothelial and smooth muscle cells in ex vivo arteries
- 23 April 2007
- journal article
- research article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 118 (3), 285-293
- https://doi.org/10.1016/j.jconrel.2006.12.029
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Mechanism of intracellular delivery by acoustic cavitationJapanese Journal of Clinical Oncology, 2006
- Encapsulated ultrasound microbubbles: Therapeutic application in drug/gene deliveryJournal of Controlled Release, 2006
- Angiogenic and antiangiogenic gene therapyGene Therapy, 2005
- Plasma membrane poration induced by ultrasound exposure: Implication for drug deliveryJournal of Controlled Release, 2005
- Vascular effects induced by combined 1-MHz ultrasound and microbubble contrast agent treatments in vivoJapanese Journal of Clinical Oncology, 2005
- Endothelium-Targeted Gene and Cell-Based Therapies for Cardiovascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Local delivery of E2F decoy oligodeoxynucleotides using ultrasound with microbubble agent (Optison) inhibits intimal hyperplasia after balloon injury in rat carotid artery modelBiochemical and Biophysical Research Communications, 2004
- Ultrasound contrast agents: properties, principles of action, tolerance, and artifactsEuropean Radiology, 2001
- High-efficiency endovascular gene delivery via therapeutic ultrasoundJournal of the American College of Cardiology, 2001
- The endothelium: a new target for therapyVascular Medicine, 2000